| No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized, double-blind, placebo-controlled, crossover study IMP Linares, FS Guimaraes, A Eckeli, ACS Crippa, AW Zuardi, JDS Souza, ... Frontiers in pharmacology 9, 315, 2018 | 94 | 2018 |
| Efficacy and safety of cannabidiol plus standard care vs standard care alone for the treatment of emotional exhaustion and burnout among frontline health care workers during … JAS Crippa, AW Zuardi, FS Guimarães, AC Campos, F de Lima Osório, ... JAMA network open 4 (8), e2120603-e2120603, 2021 | 75 | 2021 |
| Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE Study): a randomized, double-blind, placebo-controlled clinical trial JAS Crippa, JC Pacheco, AW Zuardi, FS Guimarães, AC Campos, ... Cannabis and cannabinoid research 7 (5), 658-669, 2022 | 35 | 2022 |
| Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022) JDR Souza, JC Pacheco, GN Rossi, BO de-Paulo, AW Zuardi, ... Pharmaceutics 14 (12), 2598, 2022 | 32 | 2022 |
| Clinical issues in cannabis use Y Bonomo, JDS Souza, A Jackson, JAS Crippa, N Solowij British journal of clinical pharmacology 84 (11), 2495-2498, 2018 | 29 | 2018 |
| Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic JDS Souza, AW Zuardi, FS Guimarães, FL Osório, SR Loureiro, ... Frontiers in Pharmacology 13, 856846, 2022 | 18 | 2022 |
| Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic JC Pacheco, JDS Souza, JEC Hallak, F de Lima Osório, AC Campos, ... Journal of Clinical Psychopharmacology 41 (3), 327-329, 2021 | 15 | 2021 |
| Burnout and Distress Prevention With Cannabidiol in Front-line Health Care Workers Dealing With COVID-19 (BONSAI) Trial Investigators: Efficacy and safety of cannabidiol plus … JAS Crippa, AW Zuardi, FS Guimarães, AC Campos, F de Lima Osório, ... JAMA Netw Open 4 (8), e2120603, 2021 | 12 | 2021 |
| Cannabidiol-induced skin rash: a case series and key recommendations JDS Souza, MF Ribeiro, RM Batista, JM Ushirohira, AW Zuardi, ... Frontiers in Pharmacology, 1265, 2022 | 8* | 2022 |
| Does the “entourage effect” in cannabinoids exist? A narrative scoping review JLQ Simei, JDR Souza, JR Lisboa, AC Campos, FS Guimarães, A Zuardi, ... Cannabis and cannabinoid research 9 (5), 1202-1216, 2024 | 6 | 2024 |
| Cannabidiol in anxiety disorders: Current and future perspectives. JLQ Simei, JDR de Souza, JR Lisboa, FS Guimarães, JAS Crippa International Review of Neurobiology 177, 205-234, 2024 | 1 | 2024 |
| Biomarkers in Anxiety Disorders JRF Lisboa, JDR Souza, FV Gomes, FS Guimarães, JAS Crippa Biomarkers in Neuropsychiatry: A Primer, 233-265, 2023 | 1 | 2023 |
| Emerging synthetic cannabinoids and the risk of psychosis: a growing concern for public health JDR Souza, CS Madruga, C Noto Brazilian Journal of Psychiatry 45 (4), 306-307, 2023 | 1 | 2023 |
| Efeitos do canabidiol na saúde mental de profissionais de saúde da linha de frente durante a pandemia de COVID-19: um estudo clínico randomizado e avaliação longitudinal JDR Souza | | 2024 |
| The Use of Cannabinoids in Clinical Psychiatry JDR de Souza, JA Crippa Psychiatric Annals 53 (6), 239-240, 2023 | | 2023 |
| Canabidiol na Medicina: da pesquisa à prática clínica AWZ JAS Crippa, JDR Souza, FS Guimarães Editora Manole 1, 368, 2023 | | 2023 |
| Cannabidiol as a Treatment for Schizophrenia FVG JRF Lisboa, JL Simei, JDR de Souza Psychiatric Annals 53 (6), 252–255, 2023 | | 2023 |
| Uso de canabinoides nos distúrbios do movimento V Tumas, JAS Crippa, JDS Souza PRONEURO: Programa de Atualização em Neurologia: Ciclo 1 4, 137-160, 2021 | | 2021 |
| Maconha AW Zuardi, Crippa, José Alexandre S, Souza, José Diogo S Dependência Química Prevenção, Tratamento e Políticas Públicas 2, 2019 | | 2019 |
José Alexandre de Souza CrippaFaculdade de Medicina de Ribeirão Preto在 fmrp.usp.br 的电子邮件经过验证
